J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizvi, M.
Right arrow Articles by Afzal, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizvi, M.
Right arrow Articles by Afzal, K.
Agricola
Right arrow Articles by Rizvi, M.
Right arrow Articles by Afzal, K.
J Med Microbiol 57 (2008), 382-383; DOI: 10.1099/jmm.0.47512-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Case Report

Stomatococcus mucilaginosus meningitis in a healthy 2-month-old child

Meher Rizvi1, Nazish Fatima1, Indu Shukla1 and Kamran Afzal2

1 Department of Microbiology, JN Medical College, Aligarh Muslim University, Aligarh (UP) 202002, India

2 Department of Paediatrics, JN Medical College, Aligarh Muslim University, Aligarh (UP) 202002, India

Correspondence
Meher Rizvi
rizvimeher{at}yahoo.co.in

Received 15 July 2007
Accepted 24 October 2007

Stomatococcus mucilaginosus is a Gram-positive, catalase-variable organism considered part of the normal human oral and upper respiratory tract flora. Although traditionally believed to be an organism of low virulence, Stomatococcus mucilaginosus has been reported to be an opportunistic pathogen in immunocompromised patients. We describe what we believe is the first reported case of Stomatococcus mucilaginosus meningitis in a healthy child. The isolate was multidrug-resistant, susceptible only to vancomycin. The patient was treated successfully with vancomycin after initial trials with amikacin and cefotaxime.

Abbreviations: CSF, cerebrospinal fluid.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.